Bill113th Congress

H.R. 1930

Drug Testing Integrity Act of 2013

Ask AI
Introduced
May 9, 2013
Origin Chamber
House
Policy Area
Commerce
Latest Action
May 10, 2013
Latest Action

Referred to the Subcommittee on Commerce, Manufacturing, and Trade.

Sponsor

Rep. Engel, Eliot L. [D-NY-16]

Democrat·NY-16
First Name: ELIOT
Middle Name: L.
Last Name: ENGEL
By Request: N
1
Cosponsors
1
Committees
4
Actions
0
Amendments
0
Related Bills
4
Subjects
1
Summaries
3
Titles
1
Text Versions

Bill Details

Update Date
Nov 15, 2022
Origin Chamber
House
Bill Type
HR
Bill Number
1,930
Congress
113
Introduced Date
May 9, 2013
Policy Area
Commerce
Is Law
No
May 10, 2013Committee

Referred to the Subcommittee on Commerce, Manufacturing, and Trade.

Source: House committee actions

May 9, 2013IntroReferralH11100

Referred to the House Committee on Energy and Commerce.

Source: House floor actions

May 9, 2013IntroReferralIntro-H

Introduced in House

Source: Library of Congress

May 9, 2013IntroReferral1000

Introduced in House

Source: Library of Congress

Introduced in House· May 9, 20130

Drug Testing Integrity Act of 2013 - Makes it unlawful to knowingly manufacture, market, sell, ship, or otherwise provide to another individual any product with the intent to assist such individual to use such product to defraud a drug test.

Treats a violation of this Act as an unfair or deceptive act or practice under the Federal Trade Commission Act.

Energy and Commerce Committee

House· Standing
Drug trafficking and controlled substancesDrug, alcohol, tobacco useFraud offenses and financial crimesMedical tests and diagnostic methods

Introduced in House

May 9, 2013

VIEW
Drug Testing Integrity Act of 2013 — Informed